FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1036203737> ?p ?o ?g. }

• W1036203737 endingPage "46" @default.
• W1036203737 startingPage "131" @default.
• W1036203737 abstract "This study on the appearance, distribution and kinetics of fibroblast-like cells (fat-storing cells, transitional cells, myofibroblasts and fibroblasts) after CCl4-treatment was undertaken to delineate further the respective roles of these cell types in liver fibrogenesis. The different cell types were distinguished on the basis of their immunophenotypic pattern with a combination of marker antibodies and on the basis of ultrastructural characteristics. Combined staining for alpha-smooth muscle actin (sma) and desmin (Des) revealed perisinusoidal fat-storing cells (FSC) as d+ sma- and myofibroblasts around the central veins of the normal rat liver as d+ sma+. During the initial phase of CCl4-induced hepatic fibrosis (week 1 and 2), the number of d+ sma+ cells increased in the degenerating area around the central veins and d+ sma+ cells appeared in the very thin fibrotic septa at week 2. Ultrastructural examination of the affected central areas showed the presence of myofibroblasts. These sma+ cells proliferated, as shown by double staining for bromodeoxyuridine (BrdU) and sma. In degenerating parenchymal areas, d+ sma- FSC were present. The FSC in the perisinusoidal space of areas which were not affected by CCl4 intoxification, remained d+ sma-. These immunostaining findings support the electron microscopical results, which show the presence of cells with the typical ultrastructural characteristics of FSC in both the degenerating areas and the perisinusoidal space of unaffected areas. After one week of CCl4-treatment, enhanced deposition of procollagen type III was observed around the central veins. Enhanced deposition of collagen type IV was seen subendothelially along the sinusoids, notably in degenerating parenchymal areas where the septa were later formed. FSC appear to be the principal source of collagen type IV during fibrogenesis. These observations further support and specify the role of FSC in early fibrogenesis. With the progression of the CCl4-induced fibrosis, d+ sma+ myofibroblasts remained localized in the fibrotic septa, but now along their outer edge. The majority of the cells in the septa were formed by d- sma- cells indicating a prominent role of fibroblasts in the septal formation. Septal fibroblasts are not only likely to produce matrix components, but also were shown to degrade collagen, as evidenced by the increased number of collagen-containing vacuoles during the course of fibrosis. In conclusion, myofibroblasts and FSC appear to be the main cell types involved in the initial phase of liver fibrogenesis induced by CCl4. Both myofibroblasts and FSC divide and transform.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W1036203737 created "2016-06-24" @default.
• W1036203737 creator A5000742878 @default.
• W1036203737 creator A5002776567 @default.
• W1036203737 creator A5020584350 @default.
• W1036203737 creator A5058441096 @default.
• W1036203737 creator A5059069685 @default.
• W1036203737 creator A5062019573 @default.
• W1036203737 creator A5070604689 @default.
• W1036203737 creator A5078932811 @default.
• W1036203737 creator A5082192614 @default.
• W1036203737 date "1994-04-01" @default.
• W1036203737 modified "2023-09-23" @default.
• W1036203737 title "Fat-storing cells and myofibroblasts are involved in the initial phase of carbon tetrachloride-induced hepatic fibrosis in BN/BiRij rats." @default.
• W1036203737 cites W1218841746 @default.
• W1036203737 cites W1485578090 @default.
• W1036203737 cites W1977929797 @default.
• W1036203737 cites W1983062597 @default.
• W1036203737 cites W1988212449 @default.
• W1036203737 cites W1993831741 @default.
• W1036203737 cites W2006270017 @default.
• W1036203737 cites W2008249181 @default.
• W1036203737 cites W2010846405 @default.
• W1036203737 cites W2021964163 @default.
• W1036203737 cites W2026167796 @default.
• W1036203737 cites W2030503702 @default.
• W1036203737 cites W2034067448 @default.
• W1036203737 cites W2040361469 @default.
• W1036203737 cites W2040617968 @default.
• W1036203737 cites W2085799846 @default.
• W1036203737 cites W2088071075 @default.
• W1036203737 cites W2112426232 @default.
• W1036203737 cites W2122153903 @default.
• W1036203737 cites W2124314287 @default.
• W1036203737 cites W2159321336 @default.
• W1036203737 cites W2170202796 @default.
• W1036203737 cites W2170910044 @default.
• W1036203737 cites W2363784821 @default.
• W1036203737 cites W2396199971 @default.
• W1036203737 cites W2397730899 @default.
• W1036203737 cites W2409512345 @default.
• W1036203737 cites W2416865480 @default.
• W1036203737 cites W2422827395 @default.
• W1036203737 cites W1999078180 @default.
• W1036203737 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2002098" @default.
• W1036203737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8199005" @default.
• W1036203737 hasPublicationYear "1994" @default.
• W1036203737 type Work @default.
• W1036203737 sameAs 1036203737 @default.
• W1036203737 citedByCount "4" @default.
• W1036203737 countsByYear W10362037372016 @default.
• W1036203737 crossrefType "journal-article" @default.
• W1036203737 hasAuthorship W1036203737A5000742878 @default.
• W1036203737 hasAuthorship W1036203737A5002776567 @default.
• W1036203737 hasAuthorship W1036203737A5020584350 @default.
• W1036203737 hasAuthorship W1036203737A5058441096 @default.
• W1036203737 hasAuthorship W1036203737A5059069685 @default.
• W1036203737 hasAuthorship W1036203737A5062019573 @default.
• W1036203737 hasAuthorship W1036203737A5070604689 @default.
• W1036203737 hasAuthorship W1036203737A5078932811 @default.
• W1036203737 hasAuthorship W1036203737A5082192614 @default.
• W1036203737 hasConcept C142724271 @default.
• W1036203737 hasConcept C147447768 @default.
• W1036203737 hasConcept C176891718 @default.
• W1036203737 hasConcept C185592680 @default.
• W1036203737 hasConcept C202751555 @default.
• W1036203737 hasConcept C204232928 @default.
• W1036203737 hasConcept C207865475 @default.
• W1036203737 hasConcept C2776200302 @default.
• W1036203737 hasConcept C2779072444 @default.
• W1036203737 hasConcept C2780559512 @default.
• W1036203737 hasConcept C2993667909 @default.
• W1036203737 hasConcept C55450435 @default.
• W1036203737 hasConcept C55493867 @default.
• W1036203737 hasConcept C71924100 @default.
• W1036203737 hasConcept C86803240 @default.
• W1036203737 hasConceptScore W1036203737C142724271 @default.
• W1036203737 hasConceptScore W1036203737C147447768 @default.
• W1036203737 hasConceptScore W1036203737C176891718 @default.
• W1036203737 hasConceptScore W1036203737C185592680 @default.
• W1036203737 hasConceptScore W1036203737C202751555 @default.
• W1036203737 hasConceptScore W1036203737C204232928 @default.
• W1036203737 hasConceptScore W1036203737C207865475 @default.
• W1036203737 hasConceptScore W1036203737C2776200302 @default.
• W1036203737 hasConceptScore W1036203737C2779072444 @default.
• W1036203737 hasConceptScore W1036203737C2780559512 @default.
• W1036203737 hasConceptScore W1036203737C2993667909 @default.
• W1036203737 hasConceptScore W1036203737C55450435 @default.
• W1036203737 hasConceptScore W1036203737C55493867 @default.
• W1036203737 hasConceptScore W1036203737C71924100 @default.
• W1036203737 hasConceptScore W1036203737C86803240 @default.
• W1036203737 hasIssue "2" @default.
• W1036203737 hasLocation W10362037371 @default.
• W1036203737 hasOpenAccess W1036203737 @default.
• W1036203737 hasPrimaryLocation W10362037371 @default.
• W1036203737 hasRelatedWork W1959565368 @default.
• W1036203737 hasRelatedWork W2018971514 @default.
• W1036203737 hasRelatedWork W2039876496 @default.

• next